Home » Newsroom » In the media » Pulse 2.0: Evogene Builds Six Active Drug Collaborations While Retaining Commercial Rights To Resulting Discoveries
Our website uses cookies to provide optimal performance and improve your viewing experience. Please accept cookies to continue.